These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7466779)

  • 1. The HLA--B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1980 Apr; 15(4):389-97. PubMed ID: 7466779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HLA-B12 and -B40 cross-reactive groups and their serological relationships.
    Darke C
    Tissue Antigens; 1983 Apr; 21(4):281-95. PubMed ID: 6190263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serological study of the HLA-B17 cross-reactive group.
    Darke C
    Tissue Antigens; 1984 Mar; 23(3):141-50. PubMed ID: 6203186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of HLA antigens on lymphoblastoid and epithelial cell lines and cross-reactivity of HLA-Cw5 and HLA-Cw8.
    O'Toole CM; Lewis CM; Wolf E
    Hum Immunol; 1983 Mar; 6(3):119-31. PubMed ID: 6841162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A F(ab')2 fragment blocking study of the HLA-B14 antigen.
    Darke C
    Tissue Antigens; 1985 Apr; 25(4):177-86. PubMed ID: 2409633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross reactivity in the HLA region.
    Naik S; Wong DM; Mittal KK
    Acta Anthropogenet; 1983; 7(3):219-32. PubMed ID: 6335044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reanalysis of the HLA-B7 cross-reactive group.
    Darke C
    Tissue Antigens; 1983 Nov; 22(5):326-34. PubMed ID: 6606863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of responder cell activity in mixed leukocyte culture reactions. II. Influence of antibody binding and shedding properties within a B7-cross-reactivity group.
    de Rooij-Doyer E; Schoen MA; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Oct; 18(4):205-16. PubMed ID: 6178176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitopes and motifs of the HLA-B*14 allele family products and related HLA-B14 cross-reactive specificities.
    Street J; Darke C
    Int J Immunogenet; 2017 Oct; 44(5):225-233. PubMed ID: 28691368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactions of HLA antibodies: VII. Rate of sensitization and serological specificity.
    Kostyu DD; Bernard NF; Amos DB
    Tissue Antigens; 1979 Apr; 13(4):298-306. PubMed ID: 88777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
    de Rooij-Doyer E; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A public antigenic determinant in the HLA-B5 cross-reacting group--a basis for cross-reactivity and a possible link with Behcet's disease.
    Schwartz BD; Luehrman LK; Lee J; Rodey GE
    Hum Immunol; 1980 Jul; 1(1):37-54. PubMed ID: 6167541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet transfusion from donors mismatched for crossreactive HLA antigens.
    Dahlke MB; Weiss KL
    Transfusion; 1984; 24(4):299-302. PubMed ID: 6464151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological analysis of xenogeneic anti-lymphoblastoid cell-line sera with specificity against HLA-B12.
    Schäfer K; Albert ED; Rodt H; Thierfelder S
    Immunogenetics; 1980; 10(6):595-602. PubMed ID: 22457938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric HLA-B27 screening: cross-reactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens.
    Levering WH; Wind H; Sintnicolaas K; Hooijkaas H; Gratama JW
    Cytometry B Clin Cytom; 2003 Jul; 54(1):28-38. PubMed ID: 12827665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target antigens of cell-mediated lympholysis discrimination of HLA subtypes by cytotoxic lymphocytes.
    Robinson MA; Noreen HJ; Amos DB; Yunis EJ
    J Immunol; 1978 Oct; 121(4):1486-90. PubMed ID: 701804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inclusion of HLA-Bw42, Bw54 and Bw55 within the HLA-B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1983 Mar; 21(3):246-53. PubMed ID: 6190262
    [No Abstract]   [Full Text] [Related]  

  • 18. Constancy of cross reactivity patterns during the anti-HL-A response.
    Longo A; Tosi RM; Ferrara G; Azzolina G; Carminati G
    Transplantation; 1975 Dec; 20(6):503-11. PubMed ID: 1209727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feasibility study of human leukocyte antigen (HLA) typing for dried bloodstains.
    Nelson MS; Turner LL; Reisner EG
    J Forensic Sci; 1983 Jul; 28(3):608-14. PubMed ID: 6619780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.